OH-PROAMPAC
1.5.2023 16:18:28 CEST | Business Wire | Press release
ProAmpac, a leader in flexible packaging and material science, will showcase its products at Interpack, a worldwide exhibition for the packaging industry, in Hall 10, Stand D21. The event is scheduled to take place in Dusseldorf, Germany, from 4-10 May.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230501005442/en/
ProActive Recyclable R-2050 is a high-performance mono PE recyclable film that features superior heat resistance, excellent directional tear for easy opening and various barrier properties available to suit even the most sensitive products. (Photo: Business Wire)
"We're thrilled to be back at Interpack this year with sustainable packaging innovation and our expanded capabilities in Europe, Ireland, and the UK. Our recent additions, such as digital printing, spouted and aseptic pouching, and our commitment to ESG goals, enable us to collaborate on the latest innovations in flexible packaging," states Adam Grose, chief commercial officer for ProAmpac.
Sustainable Packaging Innovations
ProAmpac will showcase its sustainable offerings with its ProActive Sustainability® line of packaging. New product innovations on display include:
- ProActive Recyclable R-2050. This high-performance mono PE recyclable film features superior heat resistance, excellent directional tear for easy opening and various barrier properties available to suit even the most sensitive products.
- QUADLFEX Recyclable is a film-based quad packaging solution that is perfect for high-speed filling lines. This packaging can be customized with clear windows and surface finishes and is preapproved for recycling through the in-store drop-off program.
- ProActive Recyclable RP-1000, a recyclable paper-based product that provides barrier protection for dry and non-greasy food products.
- PRO-EVO Recyclable provides excellent grease and edge-wicking resistance without intentionally adding per- and poly-fluoroalkyl substances (PFAS). PRO-EVO Recyclable is also available with a high moisture barrier to maintain the freshness of pet foods.
- RAP Packaging Products keeps food to-go fresh and offers an elevated appearance in either a hot cabinet or a chiller. Also, by weight, the largest packaging component is paperboard and paper sourced from well-managed forests, which is widely recyclable in fibre streams. ProAmpac’s food to-go packaging solutions are 2023 OPRL 90/10 compliant.
- ProActive PIR film contains 30% polyethylene-based postindustrial recycled content, meets UK Plastic Packaging Tax guidelines for tax exemption and is OPRL compliant for front-of-store drop-off. All virgin material and film used to produce ProActive PIR film are EU food contact grade materials, which comply with Regulation (EU) No 10/2011 and have also undergone additional NIAS testing.
Thought Leadership
On Monday, 8 May, at 11:00 am, Sal Pellingra, the vice president of global package design, applications, and business development at ProAmpac, will be presenting ProAmpac's Approach to Sustainability at the Interpack TV Stage, situated between Halls 7 and 9 at the North Entrance. During the presentation, Sal will highlight sustainable market trends and ProAmpac’s collaborative approach to commercialization of new ProActive Sustainability® technologies toward a more circular economy.
To set up a meeting during the show or learn how ProAmpac’s team can help you, please contact Events@ProAmpac.com or visit ProAmpac.com.
About ProAmpac
ProAmpac is a leading global flexible packaging company with a comprehensive product offering, providing creative packaging solutions, industry-leading customer service and award-winning innovation to a diverse global marketplace. ProAmpac’s approach to sustainability – ProActive Sustainability® – provides innovative sustainable flexible packaging products to help our customers achieve their sustainability goals. We are guided in our work by five core values that are the basis for our success: Integrity, Intensity, Innovation, Involvement and Impact. Cincinnati-based ProAmpac is owned by Pritzker Private Capital along with management and co-investors. For more information, visit ProAmpac.com or contact Media@ProAmpac.com.
About Pritzker Private Capital
Pritzker Private Capital partners with middle-market companies based in North America with leading positions in the manufactured products and services sectors. The firm's differentiated, long duration capital base allows for efficient decision-making, broad flexibility with transaction structure and investment horizon, and alignment with all stakeholders. Pritzker Private Capital builds businesses for the long term and is an ideal partner for entrepreneur- and family-owned companies. Pritzker Private Capital is a signatory to the United Nations Principles for Responsible Investment (PRI). For more information, visit PPCPartners.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230501005442/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom